Contact Us | Site Index | Legal

Investor Relations

The investor pages that follow are your resource for financial information about Progenics Pharmaceuticals, Inc.. In this section you will find information about our current and historical share price, analyst coverage, SEC filings, an electronic version of our annual report and frequently asked questions as well as forms to request additional information.

Corporate Presentation

Recent Releases

Feb 4, 2010
Progenics Presents Novel Multiplex PI3-Kinase Inhibitors at American Association for Cancer Research Conference on Protein Translation and Cancer

Nov 9, 2009
CORRECTING and REPLACING Progenics Announces Third Quarter 2009 Financial Results

Nov 9, 2009
Progenics Announces Third Quarter 2009 Financial Results

more »

Events

Feb 3, 2010
American Association for Cancer Research (AACR) Conference on Protein Translation and Cancer

Jan 11, 2010
28th Annual J.P. Morgan Healthcare Conference

more »